Press Releases:

July 16, 2010
Epizyme Scientists Detail Epigenetic Approaches to Cancer Therapy in Drug Discovery Today: Therapeutic Strategies and Current Opinion in Chemical Biology

May 21, 2010
Transforming Cancer Therapy via HMT Inhibition, MSA Partners, Japan (English)

Transforming Cancer Therapy via HMT Inhibition, MSA Partners, Japan (Japanese)

May 14, 2010
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery

March 24, 2010
Epizyme Expands Leadership Team, Appointing Robert Gould, Ph.D. as CEO and Jason Rhodes as EVP and CBO

December 8, 2009
Epizyme Closes $40M Series B Financing NEA Joins Syndicate;
NEA's David Mott Joins Board

October 23, 2009
Epizyme Appoints Hoyoung Huh, MD, Ph.D., Chairman of the Board of Directors

October 7, 2009
Epizyme Closes $32 Million Series B Financing, Led By New Investor Bay City Capital

September 9, 2009
Nature Reviews Drug Discovery
Publishes Epizyme-authored Paper on Protein Methyltransferases

In Print:
Epizyme featured by BusinessWeek as one of the
most innovative new start-ups